TAMPA, Fla.--(BUSINESS WIRE)--The results of the 2023 National Diabetes Care Survey, a longitudinal analysis of patients with Type 2 diabetes in the United States, have been released and provide ...

Basch et al 10 have called for recognition of ePRO symptom monitoring as a digital therapeutic intervention that improves cancer outcomes. If ePROs are recognized as a therapeutic, this would allow ...